|
G |
ADGRE4P |
adhesion G protein-coupled receptor E4, pseudogene |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of ADGRE4 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr19:6,950,758...6,997,851
Ensembl chr19:6,954,659...6,990,798
|
|
G |
ADGRE5 |
adhesion G protein-coupled receptor E5 |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of ADGRE5 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr19:14,381,444...14,408,723
Ensembl chr19:14,380,501...14,408,725
|
|
G |
AFP |
alpha fetoprotein |
multiple interactions decreases expression |
ISO |
S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of AFP mRNA] S-Adenosylmethionine results in decreased expression of AFP mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 4:73,436,221...73,456,174
Ensembl chr 4:73,431,138...73,456,174
|
|
G |
AHR |
aryl hydrocarbon receptor |
multiple interactions decreases abundance |
ISO |
PEMT protein promotes the reaction [AHR protein results in decreased abundance of S-Adenosylmethionine] |
CTD |
PMID:29416063 |
|
NCBI chr 7:17,298,652...17,346,147
Ensembl chr 7:16,916,359...17,346,152
|
|
G |
ALAD |
aminolevulinate dehydratase |
increases activity |
ISO |
S-Adenosylmethionine results in increased activity of ALAD protein |
CTD |
PMID:9559101 |
|
NCBI chr 9:113,386,312...113,401,284
Ensembl chr 9:113,386,312...113,401,290
|
|
G |
ALAS2 |
5'-aminolevulinate synthase 2 |
multiple interactions |
EXP |
[S-Adenosylmethionine co-treated with Hemin] results in increased expression of ALAS2 mRNA; catechol inhibits the reaction [[S-Adenosylmethionine co-treated with Hemin] results in increased expression of ALAS2 mRNA] |
CTD |
PMID:24141029 |
|
NCBI chr X:55,009,055...55,030,977
Ensembl chr X:55,009,055...55,030,977
|
|
G |
APP |
amyloid beta precursor protein |
increases secretion |
EXP |
S-Adenosylmethionine results in increased secretion of APP protein modified form |
CTD |
PMID:22906069 |
|
NCBI chr21:25,880,550...26,171,128
Ensembl chr21:25,880,535...26,171,128
|
|
G |
AS3MT |
arsenite methyltransferase |
multiple interactions affects binding |
EXP |
Cysteine promotes the reaction [AS3MT protein binds to S-Adenosylmethionine]; Glutathione promotes the reaction [AS3MT protein binds to S-Adenosylmethionine]; S-Adenosylmethionine promotes the reaction [AS3MT protein binds to and results in increased methylation of arsenite]; tris(2-carboxyethyl)phosphine promotes the reaction [AS3MT protein binds to S-Adenosylmethionine] |
CTD |
PMID:22955273 PMID:24124590 PMID:25349987 |
|
NCBI chr10:102,869,470...102,901,899
Ensembl chr10:102,869,470...102,901,899
|
|
G |
ATF3 |
activating transcription factor 3 |
increases expression |
ISO |
S-Adenosylmethionine results in increased expression of ATF3 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 1:212,565,407...212,620,777
Ensembl chr 1:212,565,334...212,620,777
|
|
G |
ATP7B |
ATPase copper transporting beta |
multiple interactions |
ISO |
ATP7B protein mutant form promotes the reaction [Betaine results in increased abundance of S-Adenosylmethionine] |
CTD |
PMID:22945834 |
|
NCBI chr13:51,932,669...52,012,132
Ensembl chr13:51,930,436...52,012,125
|
|
G |
BHMT2 |
betaine--homocysteine S-methyltransferase 2 |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [BHMT2 protein results in increased metabolism of Vitamin U] |
CTD |
PMID:18230605 |
|
NCBI chr 5:79,069,767...79,090,069
Ensembl chr 5:79,069,767...79,090,069
|
|
G |
CASP12 |
caspase 12 (gene/pseudogene) |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of CASP12 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr11:104,883,286...104,898,460
Ensembl chr11:104,885,718...104,898,670
|
|
G |
CASP3 |
caspase 3 |
multiple interactions decreases activity |
EXP ISO |
S-Adenosylmethionine inhibits the reaction [Ethanol results in increased activity of CASP3 protein] S-Adenosylmethionine results in decreased activity of CASP3 protein |
CTD |
PMID:17869084 PMID:18571630 |
|
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
|
|
G |
CAT |
catalase |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Acetaminophen results in decreased activity of CAT protein] |
CTD |
PMID:22683606 |
|
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
|
|
G |
CCN1 |
cellular communication network factor 1 |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [sodium arsenite results in decreased expression of CCN1 protein]; S-Adenosylmethionine inhibits the reaction [sodium arsenite results in decreased stability of CCN1 mRNA] |
CTD |
PMID:37682722 |
|
NCBI chr 1:85,580,761...85,583,950
Ensembl chr 1:85,580,761...85,584,589
|
|
G |
CDH2 |
cadherin 2 |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [sodium arsenite results in decreased expression of CDH2 protein] |
CTD |
PMID:37682722 |
|
NCBI chr18:27,932,879...28,177,130
Ensembl chr18:27,932,879...28,177,946
|
|
G |
COL1A1 |
collagen type I alpha 1 chain |
decreases expression multiple interactions |
EXP |
S-Adenosylmethionine results in decreased expression of COL1A1 mRNA S-Adenosylmethionine inhibits the reaction [LEP protein results in increased expression of COL1A1 mRNA] |
CTD |
PMID:15983038 PMID:16996477 |
|
NCBI chr17:50,184,101...50,201,631
Ensembl chr17:50,184,101...50,201,632
|
|
G |
COL1A2 |
collagen type I alpha 2 chain |
multiple interactions decreases expression |
ISO EXP |
S-Adenosylmethionine inhibits the reaction [Carbon Tetrachloride results in increased expression of COL1A2 mRNA]; S-Adenosylmethionine inhibits the reaction [SP1 protein binds to COL1A2 promoter]; S-Adenosylmethionine inhibits the reaction [TGFB1 protein binds to COL1A2 promoter] S-Adenosylmethionine results in decreased expression of COL1A2 mRNA |
CTD |
PMID:8878782 PMID:15983038 |
|
NCBI chr 7:94,394,895...94,431,227
Ensembl chr 7:94,394,895...94,431,227
|
|
G |
COMT |
catechol-O-methyltransferase |
multiple interactions |
EXP |
[tolcapone results in decreased activity of COMT protein] inhibits the reaction [Levodopa results in increased abundance of S-Adenosylmethionine] |
CTD |
PMID:16758261 |
|
NCBI chr22:19,941,772...19,969,975
Ensembl chr22:19,941,371...19,969,975
|
|
G |
CYCS |
cytochrome c, somatic |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Acetaminophen affects the localization of CYCS protein] |
CTD |
PMID:22683606 |
|
NCBI chr 7:25,118,656...25,125,260
Ensembl chr 7:25,118,656...25,125,260
|
|
G |
CYP2E1 |
cytochrome P450 family 2 subfamily E member 1 |
decreases activity multiple interactions |
EXP ISO |
S-Adenosylmethionine results in decreased activity of CYP2E1 protein S-Adenosylmethionine inhibits the reaction [CYP2E1 protein results in increased metabolism of 4-nitrophenol]; S-Adenosylmethionine inhibits the reaction [CYP2E1 protein results in increased metabolism of Dimethylnitrosamine]; S-Adenosylmethionine inhibits the reaction [CYP2E1 protein results in increased metabolism of Ethanol] S-Adenosylmethionine inhibits the reaction [Acetaminophen results in decreased expression of CYP2E1 protein]; S-Adenosylmethionine promotes the reaction [Carbon Tetrachloride results in decreased expression of and results in decreased activity of CYP2E1 protein] |
CTD |
PMID:15763544 PMID:15983038 PMID:22683606 |
|
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
|
|
G |
DDC |
dopa decarboxylase |
multiple interactions |
EXP |
[Levodopa co-treated with DDC] results in increased abundance of S-Adenosylmethionine |
CTD |
PMID:11445284 |
|
NCBI chr 7:50,458,442...50,565,405
Ensembl chr 7:50,458,436...50,565,405
|
|
G |
DLG4 |
discs large MAGUK scaffold protein 4 |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [Particulate Matter results in decreased expression of DLG4 protein] |
CTD |
PMID:27624276 |
|
NCBI chr17:7,187,187...7,220,050
Ensembl chr17:7,187,187...7,219,836
|
|
G |
DNMT1 |
DNA methyltransferase 1 |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [arsenic trioxide inhibits the reaction [DNMT1 protein binds to ESR1 promoter]]; S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in decreased expression of DNMT1 protein] |
CTD |
PMID:22558281 |
|
NCBI chr19:10,133,346...10,194,953
Ensembl chr19:10,133,342...10,231,286
|
|
G |
DNMT3A |
DNA methyltransferase 3 alpha |
multiple interactions |
EXP ISO |
S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in decreased expression of DNMT3A protein] S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of DNMT3A mRNA] |
CTD |
PMID:18098314 PMID:22558281 |
|
NCBI chr 2:25,227,874...25,342,590
Ensembl chr 2:25,227,855...25,342,590
|
|
G |
EGR1 |
early growth response 1 |
multiple interactions |
EXP |
[S-Adenosylmethionine co-treated with Arsenic] affects the expression of EGR1 mRNA; [S-Adenosylmethionine inhibits the reaction [Arsenic results in decreased methylation of EGR1 promoter]] which results in decreased expression of EGR1 mRNA; S-Adenosylmethionine inhibits the reaction [Arsenic results in decreased methylation of EGR1 promoter] |
CTD |
PMID:35490796 |
|
NCBI chr 5:138,465,479...138,469,303
Ensembl chr 5:138,465,479...138,469,303
|
|
G |
ESR1 |
estrogen receptor 1 |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [[arsenic trioxide results in increased expression of ESR1 protein] which results in increased expression of GREB1 mRNA]; S-Adenosylmethionine inhibits the reaction [[arsenic trioxide results in increased expression of ESR1 protein] which results in increased expression of TFF1 mRNA]; S-Adenosylmethionine inhibits the reaction [arsenic trioxide inhibits the reaction [DNMT1 protein binds to ESR1 promoter]]; S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in decreased methylation of ESR1 promoter]; S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in increased expression of ESR1 mRNA]; S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in increased expression of ESR1 protein] |
CTD |
PMID:22558281 |
|
NCBI chr 6:151,656,672...152,129,619
Ensembl chr 6:151,656,691...152,129,619
|
|
G |
FCGR1A |
Fc gamma receptor Ia |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of FCGR1 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 1:149,782,694...149,800,609
Ensembl chr 1:149,782,671...149,791,675
|
|
G |
FGF19 |
fibroblast growth factor 19 |
increases abundance |
ISO |
FGF19 protein results in increased abundance of S-Adenosylmethionine |
CTD |
PMID:29416063 |
|
NCBI chr11:69,698,238...69,704,022
Ensembl chr11:69,698,238...69,704,022
|
|
G |
FGL2 |
fibrinogen like 2 |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of FGL2 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 7:77,193,369...77,199,819
Ensembl chr 7:77,193,369...77,199,848
|
|
G |
GBP2 |
guanylate binding protein 2 |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of GBP2 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 1:89,106,132...89,126,114
Ensembl chr 1:89,106,132...89,150,456
|
|
G |
GCLC |
glutamate-cysteine ligase catalytic subunit |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [Lithocholic Acid affects the expression of GCLC mRNA]; S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid affects the expression of GCLC mRNA]] |
CTD |
PMID:20146260 |
|
NCBI chr 6:53,497,341...53,545,101
Ensembl chr 6:53,497,341...53,616,970
|
|
G |
GCLM |
glutamate-cysteine ligase modifier subunit |
decreases abundance |
ISO |
GCLM protein mutant form results in decreased abundance of S-Adenosylmethionine |
CTD |
PMID:38830566 |
|
NCBI chr 1:93,885,199...93,909,430
Ensembl chr 1:93,885,199...93,909,456
|
|
G |
GREB1 |
growth regulating estrogen receptor binding 1 |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [[arsenic trioxide results in increased expression of ESR1 protein] which results in increased expression of GREB1 mRNA]; S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in increased expression of GREB1 mRNA] |
CTD |
PMID:22558281 |
|
NCBI chr 2:11,482,888...11,642,788
Ensembl chr 2:11,482,341...11,642,788
|
|
G |
GSR |
glutathione-disulfide reductase |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Acetaminophen results in decreased activity of GSR protein] |
CTD |
PMID:22683606 |
|
NCBI chr 8:30,678,066...30,727,846
Ensembl chr 8:30,678,066...30,727,846
|
|
G |
GSS |
glutathione synthetase |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [Lithocholic Acid affects the expression of GSS mRNA]; S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid affects the expression of GSS mRNA]] |
CTD |
PMID:20146260 |
|
NCBI chr20:34,928,432...34,956,027
Ensembl chr20:34,928,432...34,956,027
|
|
G |
GSTM2 |
glutathione S-transferase mu 2 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of GSTM2 mRNA] |
CTD |
PMID:18098314 |
|
NCBI chr 1:109,668,057...109,683,997
Ensembl chr 1:109,668,022...109,709,551
|
|
G |
HAND2 |
heart and neural crest derivatives expressed 2 |
multiple interactions |
ISO |
[Progesterone co-treated with S-Adenosylmethionine] results in increased methylation of HAND2 promoter; S-Adenosylmethionine inhibits the reaction [Progesterone results in increased expression of HAND2 mRNA] |
CTD |
PMID:30892605 |
|
NCBI chr 4:173,526,091...173,530,229
Ensembl chr 4:173,524,969...173,530,229
|
|
G |
HBB |
hemoglobin subunit beta |
multiple interactions |
EXP |
[S-Adenosylmethionine co-treated with Hemin] results in increased expression of HBB mRNA; catechol inhibits the reaction [[S-Adenosylmethionine co-treated with Hemin] results in increased expression of HBB mRNA] |
CTD |
PMID:24141029 |
|
NCBI chr11:5,225,464...5,227,071
Ensembl chr11:5,225,464...5,229,395
|
|
G |
HDAC9 |
histone deacetylase 9 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of HDAC9 mRNA] |
CTD |
PMID:18098314 |
|
NCBI chr 7:18,086,825...19,002,416
Ensembl chr 7:18,086,949...19,002,416
|
|
G |
HLA-DRB1 |
major histocompatibility complex, class II, DR beta 1 |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of H2-EB1 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 6:32,578,775...32,589,848
Ensembl chr 6:32,577,902...32,589,848
|
|
G |
HMBS |
hydroxymethylbilane synthase |
multiple interactions |
EXP |
[S-Adenosylmethionine co-treated with Hemin] results in increased expression of HMBS mRNA; catechol inhibits the reaction [[S-Adenosylmethionine co-treated with Hemin] results in increased expression of HMBS mRNA] |
CTD |
PMID:24141029 |
|
NCBI chr11:119,084,881...119,093,549
Ensembl chr11:119,084,866...119,093,834
|
|
G |
IFI44L |
interferon induced protein 44 like |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of IFI44L mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 1:78,620,448...78,646,145
Ensembl chr 1:78,619,902...78,646,145
|
|
G |
IFNG |
interferon gamma |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of IFNG mRNA] |
CTD |
PMID:17080400 |
|
NCBI chr12:68,154,768...68,159,740
Ensembl chr12:68,154,768...68,159,740
|
|
G |
IL1B |
interleukin 1 beta |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Thioacetamide results in increased expression of IL1B protein] S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of IL1B mRNA] |
CTD |
PMID:17080400 PMID:19822164 |
|
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
|
|
G |
IL2 |
interleukin 2 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of IL2 mRNA] |
CTD |
PMID:17080400 |
|
NCBI chr 4:122,451,470...122,456,725
Ensembl chr 4:122,451,470...122,456,725
|
|
G |
IL2RG |
interleukin 2 receptor subunit gamma |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of IL2RG mRNA |
CTD |
PMID:18098314 |
|
NCBI chr X:71,107,404...71,111,577
Ensembl chr X:71,107,404...71,112,108
|
|
G |
IL36G |
interleukin 36 gamma |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of IL36G mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 2:112,978,006...112,985,658
Ensembl chr 2:112,973,203...112,985,658
|
|
G |
IL6 |
interleukin 6 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Thioacetamide results in increased expression of IL6 protein] S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of IL6 mRNA] |
CTD |
PMID:17080400 PMID:19822164 |
|
NCBI chr 7:22,727,200...22,731,998
Ensembl chr 7:22,725,884...22,732,002
|
|
G |
KLF6 |
KLF transcription factor 6 |
decreases expression multiple interactions |
ISO |
S-Adenosylmethionine results in decreased expression of KLF6 mRNA S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of KLF6 mRNA] |
CTD |
PMID:18098314 |
|
NCBI chr10:3,775,996...3,785,209
Ensembl chr10:3,775,996...3,785,281
|
|
G |
LEP |
leptin |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [LEP protein results in increased expression of COL1A1 mRNA]; S-Adenosylmethionine inhibits the reaction [Vitamin K 3 results in increased expression of LEP mRNA] |
CTD |
PMID:16996477 |
|
NCBI chr 7:128,241,278...128,257,629
Ensembl chr 7:128,241,278...128,257,629
|
|
G |
LTB |
lymphotoxin beta |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [fumonisin B1 results in increased expression of LTB mRNA] |
CTD |
PMID:17080400 |
|
NCBI chr 6:31,580,558...31,582,425
Ensembl chr 6:31,580,525...31,582,522
|
|
G |
MAF |
MAF bZIP transcription factor |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [Lithocholic Acid results in increased expression of MAF protein]; S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid results in increased expression of MAF protein]] |
CTD |
PMID:20146260 |
|
NCBI chr16:79,202,622...79,600,737
Ensembl chr16:79,585,843...79,600,737
|
|
G |
MAFG |
MAF bZIP transcription factor G |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [Lithocholic Acid results in increased expression of MAFG protein]; S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid results in increased expression of MAFG protein]] |
CTD |
PMID:20146260 |
|
NCBI chr17:81,918,270...81,931,244
Ensembl chr17:81,918,270...81,927,735
|
|
G |
MAPK1 |
mitogen-activated protein kinase 1 |
multiple interactions |
ISO EXP |
S-Adenosylmethionine inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein] [1,2-linoleoylphosphatidylcholine co-treated with S-Adenosylmethionine] inhibits the reaction [Vitamin K 3 results in increased phosphorylation of MAPK1 protein]; S-Adenosylmethionine inhibits the reaction [TGFB1 protein promotes the reaction [SP1 protein binds to MAPK1 protein modified form]] |
CTD |
PMID:15983038 PMID:16996477 |
|
NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,759,657...21,867,680
|
|
G |
MAPK3 |
mitogen-activated protein kinase 3 |
multiple interactions |
EXP ISO |
[1,2-linoleoylphosphatidylcholine co-treated with S-Adenosylmethionine] inhibits the reaction [Vitamin K 3 results in increased phosphorylation of MAPK3 protein]; S-Adenosylmethionine inhibits the reaction [TGFB1 protein promotes the reaction [SP1 protein binds to MAPK3 protein modified form]] S-Adenosylmethionine inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:15983038 PMID:16996477 |
|
NCBI chr16:30,114,105...30,123,220
Ensembl chr16:30,114,105...30,123,506
|
|
G |
MAT1A |
methionine adenosyltransferase 1A |
affects abundance increases chemical synthesis |
ISO |
MAT1A affects the abundance of S-Adenosylmethionine MAT1A protein results in increased chemical synthesis of S-Adenosylmethionine |
CTD |
PMID:8373829 PMID:12060674 |
|
NCBI chr10:80,271,820...80,289,658
Ensembl chr10:80,271,820...80,289,658
|
|
G |
MAT2A |
methionine adenosyltransferase 2A |
increases chemical synthesis |
ISO |
MAT2A protein results in increased chemical synthesis of S-Adenosylmethionine |
CTD |
PMID:8373829 |
|
NCBI chr 2:85,539,168...85,545,281
Ensembl chr 2:85,539,168...85,545,281
|
|
G |
MBD2 |
methyl-CpG binding domain protein 2 |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in increased expression of MBD2 protein] |
CTD |
PMID:22558281 |
|
NCBI chr18:54,151,606...54,224,669
Ensembl chr18:54,151,606...54,224,669
|
|
G |
MEG3 |
maternally expressed 3 |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [Arsenicals results in increased expression of MEG3 mRNA] |
CTD |
PMID:33033900 |
|
NCBI chr14:100,826,108...100,861,026
Ensembl chr14:100,779,206...100,861,031
|
|
G |
MIR491 |
microRNA 491 |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in increased expression of MIR491 mRNA] |
CTD |
PMID:24680928 |
|
NCBI chr 9:20,716,105...20,716,188
Ensembl chr 9:20,716,105...20,716,188
|
|
G |
MMP2 |
matrix metallopeptidase 2 |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [sodium arsenite results in decreased expression of MMP2 protein] |
CTD |
PMID:37682722 |
|
NCBI chr16:55,478,830...55,506,691
Ensembl chr16:55,389,700...55,506,691
|
|
G |
MTHFD1 |
methylenetetrahydrofolate dehydrogenase, cyclohydrolase and formyltetrahydrofolate synthetase 1 |
increases abundance |
ISO |
MTHFD1 protein results in increased abundance of S-Adenosylmethionine |
CTD |
PMID:19033438 |
|
NCBI chr14:64,388,353...64,460,025
Ensembl chr14:64,388,031...64,463,457
|
|
G |
MTR |
5-methyltetrahydrofolate-homocysteine methyltransferase |
affects binding multiple interactions |
EXP |
S-Adenosylmethionine binds to MTR protein [glutathionylcobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form; [Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form; Aluminum inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Arsenic inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Buthionine Sulfoximine inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Glutathione inhibits the reaction [Buthionine Sulfoximine inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]]; Glutathione inhibits the reaction [Thimerosal inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]]; Glutathione promotes the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Lead inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; mecobalamin inhibits the reaction [Buthionine Sulfoximine inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]]; Mercury inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form]; Thimerosal inhibits the reaction [[Hydroxocobalamin co-treated with S-Adenosylmethionine] results in increased activity of MTR protein alternative form] |
CTD |
PMID:17477549 PMID:26989453 |
|
NCBI chr 1:236,795,281...236,903,981
Ensembl chr 1:236,795,260...236,921,278
|
|
G |
NDRG1 |
N-myc downstream regulated 1 |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of NDRG1 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 8:133,237,175...133,297,252
Ensembl chr 8:133,237,175...133,302,022
|
|
G |
NFE2L2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
[S-Adenosylmethionine co-treated with Arsenic] results in increased expression of NFE2L2 mRNA; S-Adenosylmethionine inhibits the reaction [Lithocholic Acid results in decreased expression of NFE2L2 protein]; S-Adenosylmethionine promotes the reaction [Ursodeoxycholic Acid inhibits the reaction [Lithocholic Acid results in decreased expression of NFE2L2 protein]] |
CTD |
PMID:20146260 PMID:35490796 |
|
NCBI chr 2:177,230,303...177,264,727
Ensembl chr 2:177,218,667...177,392,756
|
|
G |
NFKBIA |
NFKB inhibitor alpha |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in increased phosphorylation of NFKBIA protein] |
CTD |
PMID:18404532 |
|
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
|
|
G |
NLGN3 |
neuroligin 3 |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [Hydrogen Peroxide results in decreased expression of NLGN3 mRNA]; S-Adenosylmethionine inhibits the reaction [Hydrogen Peroxide results in increased methylation of NLGN3 promoter]; S-Adenosylmethionine inhibits the reaction [Particulate Matter results in decreased expression of NLGN3 mRNA]; S-Adenosylmethionine inhibits the reaction [Particulate Matter results in decreased expression of NLGN3 protein]; S-Adenosylmethionine inhibits the reaction [Particulate Matter results in increased methylation of NLGN3 promoter] |
CTD |
PMID:27624276 |
|
NCBI chr X:71,144,841...71,175,307
Ensembl chr X:71,144,821...71,175,255
|
|
G |
NR0B2 |
nuclear receptor subfamily 0 group B member 2 |
increases abundance |
ISO |
NR0B2 protein results in increased abundance of S-Adenosylmethionine |
CTD |
PMID:29416063 |
|
NCBI chr 1:26,911,489...26,913,975
Ensembl chr 1:26,911,489...26,913,975
|
|
G |
NRXN1 |
neurexin 1 |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [Hydrogen Peroxide results in decreased expression of NRXN1 mRNA]; S-Adenosylmethionine inhibits the reaction [Hydrogen Peroxide results in increased methylation of NRXN1 promoter]; S-Adenosylmethionine inhibits the reaction [Particulate Matter results in decreased expression of NRXN1 mRNA]; S-Adenosylmethionine inhibits the reaction [Particulate Matter results in decreased expression of NRXN1 protein]; S-Adenosylmethionine inhibits the reaction [Particulate Matter results in increased methylation of NRXN1 promoter] |
CTD |
PMID:27624276 |
|
NCBI chr 2:49,918,503...51,032,132
Ensembl chr 2:49,918,503...51,225,575
|
|
G |
PARP1 |
poly(ADP-ribose) polymerase 1 |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [Arsenic results in decreased expression of PARP1 mRNA] |
CTD |
PMID:35490796 |
|
NCBI chr 1:226,360,691...226,408,093
Ensembl chr 1:226,360,210...226,408,154
|
|
G |
PDE4B |
phosphodiesterase 4B |
multiple interactions |
ISO |
[[S-Adenosylmethionine inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA]] which results in increased abundance of Cyclic AMP] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; [S-Adenosylmethionine inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA]] which results in increased abundance of Cyclic AMP; S-Adenosylmethionine inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA] |
CTD |
PMID:21266552 |
|
NCBI chr 1:65,792,510...66,374,579
Ensembl chr 1:65,792,514...66,374,579
|
|
G |
PEMT |
phosphatidylethanolamine N-methyltransferase |
multiple interactions |
ISO |
PEMT protein promotes the reaction [AHR protein results in decreased abundance of S-Adenosylmethionine] |
CTD |
PMID:29416063 |
|
NCBI chr17:17,505,563...17,592,142
Ensembl chr17:17,505,563...17,591,708
|
|
G |
PFN2 |
profilin 2 |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of PFN2 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 3:149,964,904...149,970,895
Ensembl chr 3:149,964,904...150,050,788
|
|
G |
PRDM7 |
PR/SET domain 7 |
affects binding |
EXP |
S-Adenosylmethionine binds to PRDM7 protein |
CTD |
PMID:27129774 |
|
NCBI chr16:90,056,566...90,077,331
Ensembl chr16:90,056,566...90,092,072
|
|
G |
PSMB8 |
proteasome 20S subunit beta 8 |
increases expression |
ISO |
S-Adenosylmethionine results in increased expression of PSMB8 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 6:32,840,717...32,844,679
Ensembl chr 6:32,840,717...32,844,679
|
|
G |
PTGS1 |
prostaglandin-endoperoxide synthase 1 |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of PTGS1 mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 9:122,370,533...122,395,703
Ensembl chr 9:122,370,530...122,395,703
|
|
G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
EXP |
[S-Adenosylmethionine co-treated with Arsenic] affects the expression of PTGS2 mRNA; [S-Adenosylmethionine inhibits the reaction [Arsenic results in decreased methylation of PTGS2 promoter]] which results in decreased expression of PTGS2 mRNA; S-Adenosylmethionine inhibits the reaction [Arsenic results in decreased methylation of PTGS2 promoter] |
CTD |
PMID:35490796 |
|
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
|
|
G |
RELA |
RELA proto-oncogene, NF-kB subunit |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Lipopolysaccharides results in increased activity of RELA protein] |
CTD |
PMID:21266552 |
|
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
|
|
G |
RNASEL |
ribonuclease L |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of RNASEL mRNA |
CTD |
PMID:18098314 |
|
NCBI chr 1:182,573,634...182,589,256
Ensembl chr 1:182,573,634...182,589,256
|
|
G |
SLC19A1 |
solute carrier family 19 member 1 |
affects abundance |
ISO |
SLC19A1 protein affects the abundance of S-Adenosylmethionine |
CTD |
PMID:15705887 |
|
NCBI chr21:45,502,517...45,563,025
Ensembl chr21:45,493,572...45,573,365
|
|
G |
SMYD2 |
SET and MYND domain containing 2 |
affects binding |
EXP |
S-Adenosylmethionine binds to SMYD2 protein |
CTD |
PMID:21782458 |
|
NCBI chr 1:214,281,159...214,337,131
Ensembl chr 1:214,281,102...214,337,131
|
|
G |
SOCS3 |
suppressor of cytokine signaling 3 |
multiple interactions |
EXP |
[S-Adenosylmethionine co-treated with Arsenic] affects the expression of SOCS3 mRNA; [S-Adenosylmethionine inhibits the reaction [Arsenic results in decreased methylation of SOCS3 promoter]] which results in decreased expression of SOCS3 mRNA; S-Adenosylmethionine inhibits the reaction [Arsenic results in decreased methylation of SOCS3 promoter] |
CTD |
PMID:35490796 |
|
NCBI chr17:78,356,778...78,360,925
Ensembl chr17:78,356,778...78,360,077
|
|
G |
SOD1 |
superoxide dismutase 1 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Acetaminophen results in decreased activity of SOD1 protein] |
CTD |
PMID:22683606 |
|
NCBI chr21:31,659,693...31,668,931
Ensembl chr21:31,659,666...31,668,931
|
|
G |
SOD2 |
superoxide dismutase 2 |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Acetaminophen results in decreased activity of SOD2 protein] |
CTD |
PMID:22683606 |
|
NCBI chr 6:159,669,069...159,762,281
Ensembl chr 6:159,669,069...159,762,529
|
|
G |
SP1 |
Sp1 transcription factor |
multiple interactions |
EXP ISO |
S-Adenosylmethionine inhibits the reaction [TGFB1 protein promotes the reaction [SP1 protein binds to MAPK1 protein modified form]]; S-Adenosylmethionine inhibits the reaction [TGFB1 protein promotes the reaction [SP1 protein binds to MAPK3 protein modified form]] S-Adenosylmethionine inhibits the reaction [SP1 protein binds to COL1A2 promoter] |
CTD |
PMID:15983038 |
|
NCBI chr12:53,380,176...53,416,446
Ensembl chr12:53,380,176...53,416,446
|
|
G |
SYN1 |
synapsin I |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [Particulate Matter results in decreased expression of SYN1 protein] |
CTD |
PMID:27624276 |
|
NCBI chr X:47,571,901...47,619,857
Ensembl chr X:47,571,901...47,619,857
|
|
G |
TF |
transferrin |
multiple interactions increases expression |
ISO |
[S-Adenosylmethionine results in increased expression of TF protein] which affects the abundance of Iron |
CTD |
PMID:18571630 |
|
NCBI chr 3:133,661,998...133,796,641
Ensembl chr 3:133,746,040...133,796,641
|
|
G |
TFF1 |
trefoil factor 1 |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [[arsenic trioxide results in increased expression of ESR1 protein] which results in increased expression of TFF1 mRNA]; S-Adenosylmethionine inhibits the reaction [arsenic trioxide results in increased expression of TFF1 mRNA] |
CTD |
PMID:22558281 |
|
NCBI chr21:42,362,282...42,366,535
Ensembl chr21:42,362,282...42,366,535
|
|
G |
TFRC |
transferrin receptor |
decreases expression |
ISO |
S-Adenosylmethionine results in decreased expression of TFRC mRNA |
CTD |
PMID:18571630 |
|
NCBI chr 3:196,049,284...196,082,090
Ensembl chr 3:196,012,511...196,082,153
|
|
G |
TGFB1 |
transforming growth factor beta 1 |
multiple interactions |
EXP ISO |
S-Adenosylmethionine inhibits the reaction [TGFB1 protein promotes the reaction [SP1 protein binds to MAPK1 protein modified form]]; S-Adenosylmethionine inhibits the reaction [TGFB1 protein promotes the reaction [SP1 protein binds to MAPK3 protein modified form]] S-Adenosylmethionine inhibits the reaction [Carbon Tetrachloride results in increased expression of TGFB1 protein]; S-Adenosylmethionine inhibits the reaction [TGFB1 protein binds to COL1A2 promoter]; S-Adenosylmethionine inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK1 protein]; S-Adenosylmethionine inhibits the reaction [TGFB1 protein results in increased phosphorylation of MAPK3 protein] |
CTD |
PMID:15983038 |
|
NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
|
|
G |
TNF |
tumor necrosis factor |
multiple interactions |
ISO |
[[S-Adenosylmethionine inhibits the reaction [Lipopolysaccharides results in increased expression of PDE4B mRNA]] which results in increased abundance of Cyclic AMP] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein] S-Adenosylmethionine inhibits the reaction [Thioacetamide results in increased expression of TNF protein] |
CTD |
PMID:19822164 PMID:21266552 |
|
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
|
|
G |
TPMT |
thiopurine S-methyltransferase |
multiple interactions |
EXP |
[S-Adenosylmethionine analog co-treated with TPMT protein] results in increased methylation of 4-methylbenzenethiol; [S-Adenosylmethionine analog co-treated with TPMT protein] results in increased methylation of 4-nitrobenzenthiol; [S-Adenosylmethionine co-treated with TPMT protein] results in increased methylation of 4-methylbenzenethiol; [S-Adenosylmethionine co-treated with TPMT protein] results in increased methylation of 4-nitrobenzenthiol; S-Adenosylmethionine analog inhibits the reaction [[S-Adenosylmethionine co-treated with TPMT protein] results in increased methylation of 4-nitrobenzenthiol]; S-Adenosylmethionine inhibits the reaction [[S-Adenosylmethionine analog co-treated with TPMT protein] results in increased methylation of 4-nitrobenzenthiol] |
CTD |
PMID:20196537 |
|
NCBI chr 6:18,128,311...18,155,169
Ensembl chr 6:18,128,311...18,155,077
|
|
G |
UBD |
ubiquitin D |
multiple interactions |
ISO |
S-Adenosylmethionine inhibits the reaction [Dicarbethoxydihydrocollidine results in increased expression of UBD mRNA] |
CTD |
PMID:18098314 |
|
NCBI chr 6:29,555,515...29,559,732
Ensembl chr 6:29,555,515...29,559,732
|
|
G |
VIM |
vimentin |
multiple interactions |
ISO EXP |
S-Adenosylmethionine inhibits the reaction [monobutyl phthalate results in increased expression of VIM mRNA]; S-Adenosylmethionine inhibits the reaction [monobutyl phthalate results in increased expression of VIM protein] S-Adenosylmethionine inhibits the reaction [sodium arsenite results in decreased expression of VIM protein] |
CTD |
PMID:26745512 PMID:37682722 |
|
NCBI chr10:17,228,241...17,237,593
Ensembl chr10:17,228,241...17,237,593
|
|
G |
XRCC1 |
X-ray repair cross complementing 1 |
multiple interactions |
EXP |
S-Adenosylmethionine inhibits the reaction [Arsenic results in decreased expression of XRCC1 mRNA] |
CTD |
PMID:35490796 |
|
NCBI chr19:43,543,311...43,575,527
Ensembl chr19:43,543,311...43,580,473
|
|